Neurotech startup Neurovalens has received FDA approval for its noninvasive anxiety treatment.
A 2019 regulatory update from the U.S. medical devices authority aimed at fostering innovation in treatments for insomnia and anxiety is showing results. Neurovalens, a startup from Belfast that has spent over a decade developing
Read more